SB2897: Give Kids a Chance Act of 2023
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
Plain-language summary
The Give Kids a Chance Act of 2023 changes federal drug approval rules to encourage research into cancer treatments designed for children. The bill amends the Federal Food, Drug, and Cosmetic Act, which governs how drugs are approved and used in the United States. "Molecularly targeted" means drugs designed to attack specific cancer cells based on their genetic makeup. The bill affects pharmaceutical companies developing childhood cancer treatments and the families of children with cancer. The bill was recently introduced in Congress and is in the early stage of the legislative process.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
SB2897: Give Kids a Chance Act of 2023
Upcoming hearings & events
Sponsors
Michael Bennet
Primary SponsorCo-sponsors (6)
Marco Rubio
Jeanne Shaheen
Edward Markey
Amy Klobuchar
Chris Van Hollen